Abstract
IntroductionLicensed anti-fibrotic medication (AFM) for IPF is limited to Pirfenidone and Nintedanib. Pirfenidone has been prescribed by the Newcastle Interstitial Lung Disease Service (NILDS) since March 2014 and Nintedanib since...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have